David Kozono
Director, Thoracic Radiation Oncology · Beth Israel Deaconess Medical Center
Credentials: · · · ·
History
- Present
- 2001–2005
Research
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2023 · 1,050 citations
From structure to disease: the evolving tale of aquaporin biology
Review · Nature Reviews Molecular Cell Biology · 2004 · 719 citations
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Nature · 2019 · 577 citations
44 papers · 1 as a resident
22 papers
17 papers
14 papers
13 papers
13 papers · 13 as a resident
13 papers · 13 as a resident
12 papers · 11 as a resident
Grants
- 2014–2032
Alliance for Clinical Trials in Oncology Operations Center
National Cancer Institute · U10
PI · $10.1M · Alliance Nctn Foundation
- 2023–2028
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science
National Cancer Institute · U54
Project lead · $1.3M · Dana-Farber Cancer Inst
- 2013–2018
Characterization of Lung Cancer Radiosensitizers from Genome-Wide RNAi Screens
National Cancer Institute · K08
Contact PI · $883.4K · Dana-Farber Cancer Inst
Clinical trials
- 2023–2028
MCT for the Harvard/UCSF ROBIN Center
Principal investigator · Recruiting
Brigham and Women's Hospital
- 2020–2021
Lung Irradiation for COVID-19 Pneumonia
Principal investigator · Withdrawn
Brigham and Women's Hospital
- 2014–2027
Principal investigator · Active not recruiting
National Cancer Institute (NCI)
- 2020–2026
Study chair · Recruiting
Alliance for Clinical Trials in Oncology